Companies

Xaira Therapeutics

xaira.com

An integrated biotechnology company leveraging artificial intelligence to transform drug discovery and disease treatment.

Employees201-1000
Funding$1B
Valuation$2.7B
Revenue$20.2M ARR
19 active roles
Healthcare AIAI ApplicationAPI / PlatformSeries A$1B+

About

Xaira Therapeutics is an integrated biotechnology company that leverages artificial intelligence to transform drug discovery and development. They develop predictive and agentic AI models and a virtual cell model to identify and modulate the right biological targets for next-generation medicines. The company operates as an AI-native biotech focusing on increasing the probability of therapeutic success while reducing development timelines and costs.

Active Roles

19
South San Francisco, California, United States/Other/6d ago
South San Francisco, California, United States/Other/7d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Engineering/13d ago
Seattle, Washington, United States/Engineering/13d ago
South San Francisco, California, United States/Engineering/13d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Other/13d ago
Seattle, Washington, United States; South San Francisco, California, United States/Legal/13d ago
South San Francisco, California, United States/Engineering/13d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Engineering/13d ago
South San Francisco, California, United States/Engineering/13d ago
South San Francisco, California, United States/Engineering/13d ago
Seattle, Washington, United States; South San Francisco, California, United States/Engineering/13d ago
South San Francisco, California, United States/Other/13d ago
South San Francisco, California, United States/Finance/13d ago

Key Investors

Arch Venture Partners, Foresite Capital, Lux Capital, SV Angel, Sequoia Capital, Menlo Ventures, NEA Partners